The Division of Hematology-Oncology evaluates and treats approximately 60 new cases of childhood cancer annually, with over 100 cancer patients on active treatment and over 350 survivors followed long-term.  We follow over 170 children and adolescents with sickle cell disease and thalassemia, and over 150 with bleeding disorders.  We have very active inpatient and outpatient services caring for the full spectrum of oncological and hematological diseases and disorders.

The division is a full member of the Children's Oncology Group and other consortiums and participates in new treatment protocols for acute leukemias, neuroblastoma, Wilms' tumor, rhabdomyosarcoma, and brain tumors. Other research activities include impact of exercise and activity on quality of life for patients with cancer, as well as prevalence of cardiac late effects in survivors of childhood cancer and methods of early detection.  We have a cancer research laboratory looking at pathways to target for novel therapies in Wilms’ tumor and Neuroblastoma.

Hematology/Oncology Faculty

Ching C. Lau, MD, PhD
Professor and Head

Donna M. Boruchov, M.D.
Assistant Professor

Eileen Gillan, M.D.
Associate Professor

Michael Isakoff, M.D.
Assistant Professor

Kerry Moss, M.D.
Assistant Clinical Professor

Andrea D. Orsey, M.D.
Assistant Professor

Ching C. Lau, MD, PhD
Ching C. Lau, MD, PhD

University of Connecticut Pediatric Residency Program, Connecticut Children's Medical Center.

Medical Education, 4H, 282 Washington Street, Hartford, CT 06106